Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor

NCT01428037 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Cervical Ripening
Induction of Labor

Interventions

DRUG: Placebo
DRUG: Misoprostol vaginal Tablet 25 mcg

Sponsor

Regenex Pharmaceutical, China